Kesimpta
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Kesimpta in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Kesimpta.
37
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Kesimpta
The latest trial results reinforce the drug’s long-term efficacy and safety profile
Approximately 85% of MS patients are initially diagnosed with relapsing forms of the neurological disease
Approximately 85% of MS patients are initially diagnosed with relapsing forms of the disease
There are an estimated 130,000 people with MS in the UK
The company has started a strategic review of Sandoz as sales drop 20% in ‘challenging’ US market
Swiss pharma company also provided key updates on a number of drug candidates in its pipeline
The data was presented virtually at the American Academy of Neurology annual meeting
New post hoc data comes from phase 3 ASCLEPIOS trials
The drug reduces the number of confirmed relapses in MS patients
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels
Swiss pharma company is expecting EU approval for treatment next year
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology